During the past decade, Sherman Clinical Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 2 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sherman Clinical Research" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 2 trials, followed by "Verona Pharma plc" with 2 trials sponsored, "Bellus Health Inc" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sherman Clinical Research" #1 collaborator was "Iqvia Pty Ltd" with 2 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sherman Clinical Research" are "Chronic Obstructive Pulmonary Disease" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Heartburn" (2 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Sherman Clinical Research" in a lesser frequency.

Most popular intervention types in "Sherman Clinical Research" are "Drug" (13 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ensifentrine" (2 trials), "Vonoprazan" (2 trials), "Astegolimab" (1 trials) and "BLU-5937" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sherman Clinical Research" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Sherman Clinical Research". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Sherman Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sherman Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".